SCHEMBL4733671

SCHEMBL4733671

CCOc1ccc(-c2cccc(C#N)c2)cc1CNC1CCC(N(C)C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.41
MCHR1 Q99705 2/20 0.39
NPBWR1 P48145 1/20 0.39
NLRP3 Q96P20 1/20 0.39
CD274 Q9NZQ7 4/20 0.39
GAA P10253 1/20 0.38
HRH2 P25021 1/20 0.38
HRH1 P35367 1/20 0.38
PDCD1 Q15116 1/20 0.38
CTSA P10619 1/20 0.38
EGLN1 Q9GZT9 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
F2R P25116 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CCR5 P51681 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4732368 0.92 MCHR1 (0.41) MCHR1NPBWR1CTSAEGLN1
SCHEMBL4731667 0.91 CD274 (0.43) IRAK4MCHR1CD274CTSA
SCHEMBL12678422 0.90 IRAK4 (0.38) IRAK4MCHR1NPBWR1NLRP3CD274
SCHEMBL12540937 0.87 IRAK4 (0.37) IRAK4MCHR1NPBWR1NLRP3CD274
SCHEMBL5616360 0.86 MCHR1 (0.38) IRAK4MCHR1NPBWR1NLRP3CD274
SCHEMBL4733667 0.85 MCHR1 (0.40) MCHR1NPBWR1CD274GAAHRH2
Hydrochloric Acid SCHEMBL4731442 0.84 NPBWR1 (0.44) IRAK4MCHR1NPBWR1CD274GAA
SCHEMBL14205325 0.84 CD274 (0.40) IRAK4MCHR1CD274CTSAEGLN1
SCHEMBL5616361 0.84 MCHR1 (0.42) MCHR1NPBWR1NLRP3CD274GAA
SCHEMBL12540936 0.84 BRD4 (0.37) MCHR1NPBWR1NLRP3CD274GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273747-B2 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin CURIS, INC. (US) 2012-09-25 US disclosed
US-20080193423-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080194637-A1 Small organic molecule regulators of cell proliferation CURIS, INC. (US) 2008-08-14 US disclosed
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin CURIS, INC. (US) 2008-07-31 US disclosed
WO-2008057497-A2 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057468-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION CURIS, INC. (US) 2008-05-15 WO disclosed
WO-2008057469-A1 SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION WYETH (US) 2008-05-15 WO disclosed
US-20080058521-A1 Processes for the preparation of compounds WYETH (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193423-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO IRAK4 4242/4885MCHR1 1785/4885NPBWR1 2518/4885
US-20080058521-A1 Processes for the preparation of compounds MKI67, MCL1, DCX IRAK4 4775/4885MCHR1 3557/4885NPBWR1 3551/4885
US-20080194637-A1 Small organic molecule regulators of cell proliferation GLI1, SHH, SMO IRAK4 4242/4885MCHR1 1785/4885NPBWR1 2518/4885
US-20080182859-A1 tert-Butyl {4-[(4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino]-cyclohexyl}-methyl-carbamate; hedgehog pathway agonists; to modulate proliferation or differentiation in a cell or tissue in vivo or vitro; alopecia; angiogenesis; wound healing; alzheimer's disease; to inhibit aging effects on skin SHH, GLI1, SMO IRAK4 2488/4885MCHR1 273/4885NPBWR1 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.